Mladx
Maastricht, NL · 1 known investors
MLA Diagnostics develops prognostic tests for early-stage melanoma, using clinically relevant methylation markers to support treatment decisions. The company works with academic and diagnostics partners in the Netherlands.
BiotechDigital HealthMedical Devices